Nektar Therapeutics
NKTR
NKTR
265 hedge funds and large institutions have $9.21B invested in Nektar Therapeutics in 2017 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 69 increasing their positions, 96 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
31% more funds holding
Funds holding: 203 → 265 (+62)
0.01% less ownership
Funds ownership: 6.56% → 6.56% (-0.01%)
28% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 96
Holders
265
Holding in Top 10
14
Calls
$183M
Puts
$31.8M
Top Buyers
| 1 | +$640M | |
| 2 | +$140M | |
| 3 | +$121M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$119M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$61.6M |
Top Sellers
| 1 | -$607M | |
| 2 | -$110M | |
| 3 | -$98.8M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$80M |
| 5 |
BM
Bridger Management
New York
|
-$54.2M |